dostarlimab
gsk
['rectal', 'dostarlimab']
ph 2 trial: neoadjuv dostarlimab for 6 mo followed by crt and surgery as needed in dmmr stage ii-iii rectal cancer (n=14) ccr 100% after 6-25 mo follow-up no patient required crt or surgery wow small trial, short follow-up... but practice changing? #asco22 
??Medical Oncologist, MSc, PhD. GI/neuroendocrine/GU tumors/breast cancer ??Hospital Universitario UFC-CE, Oncologia D’Or